Vaccines
Nippon Express Co., Ltd., a group company of Nippon Express Holdings, Inc., has become the first Japanese logistics company to collaborate with EMBAL...
June 22, 2022 | News
The development of this vaccine was funded by the National Institutes of Health (SBIR grant #R43AI058376). The company is looking for a strategic part...
June 13, 2022 | News
If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the first protein-based COVID-19 vaccine available in the...
June 09, 2022 | News
ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions Announce a New Antibody Cocktail Effective Against Major Variants of SARS-CoV-2 Prot...
June 08, 2022 | News
AcadeMab's treatment specifically targets the SARS-CoV-2 Omicron variant – currently the most common strain of COVID infections around the world. "I...
May 30, 2022 | News
In addition to shortening the vaccination cycle by leveraging the advantages of its single-dose regimen, Convidecia™ can be stably transported and st...
May 20, 2022 | News
Indonesian Health Minister Budi Gunadi Sadikin said that Southeast Asia's regional bloc agreed to solidify the three main pillars of pa...
May 18, 2022 | News
As disclosed in the prospectus of the Company dated March 21, 2022, the Group had initiated subject enrollment for the phase II/III clinical trial for...
May 06, 2022 | News
Dr. Sina Bavari, co-founder of Healion Bio, noted "Highly contagious pathogens can rarely be stopped by testing, vaccines, and hospital therapeutics alone....
April 30, 2022 | News
IQVIA Institute releases report on Lessons Learned from COVID-19 Vaccine Trials Solutions for you to dri...
April 28, 2022 | News
Data from this combination trial will inform planned Phase 2 dose confirmation trial, scheduled to begin by the end of 2022 Immune response confirmed in...
April 22, 2022 | News
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...
April 20, 2022 | News
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectiou...
April 11, 2022 | News
Partnership with CR Pharma will provide local support to navigate China regulatory pathways across mRNA vaccine platform, first in the advancemen...
April 07, 2022 | News
Most Read
Bio Jobs
News
Editor Picks